NCT06731335View on ClinicalTrials.gov

Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN

PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 5, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

December 31, 2026

Conditions
Chronic Neuropathic PainPain Management
Interventions
DRUG

Psilocybin

PSILOCYBIN (PEX010) 25 mg PO single dose

DRUG

Active Placebo

Dextromethorphan 400 mg PO single dose

Trial Locations (2)

M5B 1W8

NOT_YET_RECRUITING

St. Michael's Hospital. Unity Health Toronto, Toronto

RECRUITING

St. Michael's Hospital. Unity Health Toronto, Toronto

All Listed Sponsors
lead

Unity Health Toronto

OTHER